Fitness and Health Pfizer Discontinues Once-a-Day Experimental Obesity Pill Due to Liver Concerns0Updated:28 June, 20233 Mins Read Learn about Pfizer’s decision to discontinue its once-a-day obesity pill due to liver concerns. Discover company’s focus on developing a twice-daily treatment.